Sygnature Discovery, a drug discovery and preclinical services company, is expanding its operations with the opening of its first U.S. office in Harvard Square, Cambridge, MA.  Earlier in 2018, Sygnature appointed its first U.S. based business development representative to build on its North American presence. The U.S. is Sygnature Discovery’s largest market and with the new office the company is able to strengthen its commitment to its U.S. customer base. Sygnature Discovery’s chief execu...